Literature DB >> 8597352

Preparative regimens: chemotherapy versus chemoradiotherapy. A historical perspective.

G W Santos1.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 8597352     DOI： 10.1111/j.1749-6632.1995.tb31039.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  Hematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury.

Authors:  Lijian Shao; Yingying Wang; Jianhui Chang; Yi Luo; Aimin Meng; Daohong Zhou
Journal:  Transl Cancer Res       Date:  2013-10       Impact factor: 1.241

2.  Dynamics of early histopathological changes in GVHD after busulphan/cyclophosphamide conditioning regimen.

Authors:  Sulaiman Al-Hashmi; Zuzana Hassan; Behnam Sadeghi; Björn Rozell; Moustapha Hassan
Journal:  Int J Clin Exp Pathol       Date:  2011-07-31

3.  Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia.

Authors:  J P Uberti; M-A Agovi; S Tarima; M Haagenson; S Gandham; C Anasetti; K S Baker; B J Bolwell; M Bornhauser; K W Chan; E Copelan; S M Davies; J Finke; G A Hale; C Kollman; P L McCarthy; V Ratanatharathorn; O Ringdén; D J Weisdorf; J D Rizzo
Journal:  Bone Marrow Transplant       Date:  2010-04-19       Impact factor: 5.483

Review 4.  The Pathophysiology and Treatment of Graft-Versus-Host Disease: Lessons Learnt From Animal Models.

Authors:  Takanori Teshima; Geoffrey R Hill
Journal:  Front Immunol       Date:  2021-08-19       Impact factor: 8.786

5.  Busulfan produces efficient human cell engraftment in NOD/LtSz-Scid IL2Rgamma(null) mice.

Authors:  Jun Hayakawa; Matthew M Hsieh; Naoya Uchida; Oswald Phang; John F Tisdale
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

6.  Expansion and activation kinetics of immune cells during early phase of GVHD in mouse model based on chemotherapy conditioning.

Authors:  Behnam Sadeghi; Suleiman Al-Hashmi; Zuzana Hassan; Bjorn Rozell; Hernan Concha; Carin Lundmark; Kjell-Olov Grönvik; Manuchehr Abedi-Valugerdi; Moustapha Hassan
Journal:  Clin Dev Immunol       Date:  2010-12-21

Review 7.  Mechanisms of Tolerance Induction by Hematopoietic Chimerism: The Immune Perspective.

Authors:  Esma S Yolcu; Haval Shirwan; Nadir Askenasy
Journal:  Stem Cells Transl Med       Date:  2017-01-03       Impact factor: 6.940
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.